Best Practices for Communication Between IND Sponsors and FDA During Drug Development
Detailed guidance document from FDA and regulatory agencies.
Document Details
Good Review Practices
December 29, 2017
April 29, 2020
2c093434-6b20-4df3-af2a-d7af81ab3fd8
Related Documents
Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs
Good Review PracticesOctober 3, 2018Center for Drug Evaluation and Research
Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products Guidance for Industry
Good Review PracticesJuly 18, 2025Center for Drug Evaluation and Research
Pediatric Information Incorporated Into Human Prescription Drug and Biological Products Labeling Good Review Practice
Good Review PracticesMarch 28, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.